Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Periprosthetic Joint Infections Guided by Minimum Biofilm Eradication Concentration (MBEC) in Addition to Minimum Inhibitory Concentration (MIC); a Prospective Randomized Clinical Trial

NCT04488458 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT04488458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04488458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Periprosthetic Joint Infections Guided by Minimum Biofilm Eradication Concentration (MBEC) in Addition to Minimum Inhibitory Concentration (MIC); a Prospective Randomized Clinical Trial
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Unknown status
Start date
August 15, 2021
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip prosthesis infection, knee prosthesis infection, prosthetic infection, prosthetic joint infection